CHAI Raises $400 Million in Funding

chaitjo · x · 2026-07-15

CHAI announced the completion of a $400 million funding round led by Dimension, with participation from Index, Kleiner Perkins, and Sequoia.

The post reflected on the company's journey from sharing early office space to its current focus on generative molecular design, having secured partnerships with Lilly, Pfizer, and Novartis. It also mentioned their release of the open-source Chai-1, positioned as a frontier model for biomolecular interactions. The author emphasized that this funding round will reshape preclinical and even clinical-stage drug discovery and R&D.

Related event: AI Drug Discovery Firm Chai Raises $400M(3 posts)→

Original post →

More from Venture

Venture channel →